- Market Capitalization, $K 941,523
- Shares Outstanding, K 306,685
- Annual Sales, $ 0 K
- Annual Income, $ -35,340 K
- 60-Month Beta N/A
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 5.13
|Period||Period Low||Period High||Performance|
| || |
-0.40 (-11.53%)since 06/23/21
| || |
-0.45 (-12.78%)since 04/23/21
| || |
+2.75 (+871.52%)since 07/23/20
The obesity epidemic in the U.S. is only getting worse. In fact, by the time 2030 rolls around, nearly ...
/PRNewswire/ -- The early 1970s saw psychedelics and psilocybin products made illegal in the US in the war on drugs. Decades later, new research indicates the medical potential of psilocybin and psychedelics...
ATAI Life Sciences N.V (ATAI), Compass Pathways Plc (CMPS), and Mind Medicine Holdings (MNMD) are 3 stocks that are looking to commercialize psychedelics for medical use. Investors should keep them on...
/PRNewswire/ --What was once a war on drugs has turned into a public push for the decriminalization and legalization of illegal drugs with potential therapeutic benefits. Legalization efforts began with ...
/PRNewswire/ -- MindMed (NASDAQ: MNMD, NEO: MMED, DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that MindMed's Chief Executive Officer, , will be...
/PRNewswire/ -- MindMed (Nasdaq: MNMD, NEO: MMED, DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, and Datavant, Inc. (""), a leader in helping healthcare organizations safely...
/PRNewswire/ -- Psychedelic drugs and therapies are truly becoming mainstream and are expected to become even more so in the years to come. Psychedelic drugs involve various types of chemical substances...
Mental health is on the decline all over the world. At the moment, nearly 264 million people are ...
/PRNewswire/ -- In , listed on Nasdaq, selling 3.5 million shares at each to investors betting that GW was charting a profitable course as a biotech developing new drugs from cannabis-derived compounds....
/PRNewswire/ -- MindMed a leading psychedelic-inspired medicine company announced that effective , MindMed has been added to the FTSE Russell 3000 index which measures the performance of the largest 3,000...
|Mind Medicine Mindmed Inc|
|Advisorshares Vice ETF|
|Defiance Next Gen Altered Experience ETF|
|Oppenheimer Russell 2000 Multifactor ETF|
|Russell 2000 Ishares ETF|
|Russell 2000 Growth Ishares ETF|